Janux Therapeutics, Inc. (JANX) Documents: SEC Filings, Investor Presentations & Press Releases

Janux Therapeutics, Inc. (JANX) documents, SEC filings and the IR site together: 96 documents, newest first; latest 2026-08-06. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-06Press releaseJanux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
2026-08-068-KForm 8-K, Item 2.02 results
2026-08-0610-QForm 10-Q for the quarter ended Jun 30
2026-06-238-KForm 8-K, Item 8.01
2026-06-128-KForm 8-K, Item 5.07
2026-05-07Press releaseJanux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
2026-05-078-KForm 8-K, Item 2.02 results
2026-05-0710-QForm 10-Q for the quarter ended Mar 31
2026-04-28ProxyDefinitive proxy statement
2026-04-288-KForm 8-K, Item 5.02
2026-02-268-KForm 8-K, Item 2.02 results
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-01-26Press releaseJanux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
2026-01-228-KForm 8-K, Item 1.01
2025-12-01Press releaseJanux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC
2025-12-01DeckInvestor presentation · Q4 2025 · Dec 2025
2025-11-06Press releaseJanux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
2025-11-068-KForm 8-K, Item 2.02 results
2025-11-0610-QForm 10-Q for the quarter ended Sep 30
2025-09-198-KForm 8-K, Item 5.02
2025-08-078-KForm 8-K, Item 2.02 results
2025-08-0710-QForm 10-Q for the quarter ended Jun 30
TranscriptEarnings call transcript
2025-07-24DeckInvestor presentation · Q1 2025 · Jul 2025
2025-06-138-KForm 8-K, Item 5.07
2025-05-088-KForm 8-K, Item 2.02 results
2025-05-0810-QForm 10-Q for the quarter ended Mar 31
2025-04-25ProxyDefinitive proxy statement
2025-02-278-KForm 8-K, Item 2.02 results
2025-02-2710-KAnnual report on Form 10-K, FY24
2024-12-058-KForm 8-K, Item 8.01
2024-12-02DeckInvestor presentation · Dec 2024
2024-12-028-KForm 8-K, Item 7.01
2024-11-068-KForm 8-K, Item 2.02 results
2024-11-0610-QForm 10-Q for the quarter ended Sep 30
2024-08-078-KForm 8-K, Item 2.02 results
2024-08-0710-QForm 10-Q for the quarter ended Jun 30
2024-07-228-KForm 8-K, Item 5.02
2024-06-288-KForm 8-K, Item 5.07
2024-05-088-KForm 8-K, Item 2.02 results

JANX overview · JANX earnings · JANX financials · JANX KPIs · JANX ownership · JANX peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.